(M) Macy’s - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US55616P1049
Stock: Apparel, Accessories, Cosmetics, Home-Furnishings, Consumer-Goods
Total Rating 68
Risk 82
Buy Signal 0.31
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.81% |
| Yield on Cost 5y | 5.89% |
| Yield CAGR 5y | 24.81% |
| Payout Consistency | 92.6% |
| Payout Ratio | 30.9% |
| Risk 5d forecast | |
|---|---|
| Volatility | 47.8% |
| Relative Tail Risk | -17.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.73 |
| Alpha | 14.34 |
| Character TTM | |
|---|---|
| Beta | 1.459 |
| Beta Downside | 1.215 |
| Drawdowns 3y | |
|---|---|
| Max DD | 55.31% |
| CAGR/Max DD | -0.04 |
Description: M Macy’s January 11, 2026
Macy’s, Inc. (NYSE:M) is an omni-channel retailer operating department stores, e-commerce sites and mobile apps across the United States under the Macy’s, Bloomingdale’s and Bluemercury brands. The company also licenses its name in Dubai (UAE) and Al Zahra (Kuwait). Founded in 1830 and headquartered in New York, it rebranded from Federated Department Stores in 2007 and now competes in the Broadline Retail sub-industry.
Key recent metrics: FY 2023 net sales were approximately $24.5 billion, with comparable store sales down about 2.5% year-over-year, while digital sales grew roughly 12% on a constant-currency basis. The balance sheet carries roughly $5 billion of long-term debt, and the company’s cash conversion cycle has tightened to 70 days, reflecting ongoing inventory optimization. Primary economic drivers include consumer discretionary spending trends, inflation-adjusted disposable income, and the health of mall traffic, all of which remain volatile in the current macro environment.
For a deeper quantitative view, you might explore ValueRay’s detailed analyst dashboard to see how these factors are priced into the stock.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 478.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 5.07 > 1.0 |
| NWC/Revenue: 6.59% < 20% (prev 6.30%; Δ 0.29% < -1%) |
| CFO/TA 0.09 > 3% & CFO 1.55b > Net Income 478.0m |
| Net Debt (4.80b) to EBITDA (1.62b): 2.96 < 3 |
| Current Ratio: 1.25 > 1.5 & < 3 |
| Outstanding Shares: last quarter (274.6m) vs 12m ago -2.45% < -2% |
| Gross Margin: 40.38% > 18% (prev 0.41%; Δ 3997 % > 0.5%) |
| Asset Turnover: 132.2% > 50% (prev 135.2%; Δ -2.95% > 0%) |
| Interest Coverage Ratio: 7.37 > 6 (EBITDA TTM 1.62b / Interest Expense TTM 98.0m) |
Altman Z'' 2.58
| A: 0.09 (Total Current Assets 7.38b - Total Current Liabilities 5.89b) / Total Assets 17.06b |
| B: 0.38 (Retained Earnings 6.43b / Total Assets 17.06b) |
| C: 0.04 (EBIT TTM 722.0m / Avg Total Assets 17.18b) |
| D: 0.47 (Book Value of Equity 5.99b / Total Liabilities 12.74b) |
| Altman-Z'' Score: 2.58 = A |
Beneish M -3.29
| DSRI: 0.75 (Receivables 187.0m/258.0m, Revenue 22.71b/23.37b) |
| GMI: 1.01 (GM 40.38% / 40.86%) |
| AQI: 1.04 (AQ_t 0.15 / AQ_t-1 0.15) |
| SGI: 0.97 (Revenue 22.71b / 23.37b) |
| TATA: -0.06 (NI 478.0m - CFO 1.55b) / TA 17.06b) |
| Beneish M-Score: -3.29 (Cap -4..+1) = AA |
What is the price of M shares?
As of January 31, 2026, the stock is trading at USD 20.02 with a total of 5,712,712 shares traded.
Over the past week, the price has changed by -1.48%, over one month by -9.58%, over three months by +3.23% and over the past year by +33.09%.
Over the past week, the price has changed by -1.48%, over one month by -9.58%, over three months by +3.23% and over the past year by +33.09%.
Is M a buy, sell or hold?
Macy’s has received a consensus analysts rating of 3.15.
Therefor, it is recommend to hold M.
- StrongBuy: 2
- Buy: 0
- Hold: 10
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the M price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 21.9 | 9.4% |
| Analysts Target Price | 21.9 | 9.4% |
| ValueRay Target Price | 21.8 | 9% |
M Fundamental Data Overview January 27, 2026
P/E Trailing = 11.9529
P/E Forward = 11.2613
P/S = 0.2379
P/B = 1.2483
P/EG = 2.1667
Revenue TTM = 22.71b USD
EBIT TTM = 722.0m USD
EBITDA TTM = 1.62b USD
Long Term Debt = 2.43b USD (from longTermDebt, last quarter)
Short Term Debt = 6.00m USD (from shortTermDebt, last fiscal year)
Debt = 5.24b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.80b USD (from netDebt column, last quarter)
Enterprise Value = 10.20b USD (5.40b + Debt 5.24b - CCE 447.0m)
Interest Coverage Ratio = 7.37 (Ebit TTM 722.0m / Interest Expense TTM 98.0m)
EV/FCF = 9.38x (Enterprise Value 10.20b / FCF TTM 1.09b)
FCF Yield = 10.66% (FCF TTM 1.09b / Enterprise Value 10.20b)
FCF Margin = 4.79% (FCF TTM 1.09b / Revenue TTM 22.71b)
Net Margin = 2.10% (Net Income TTM 478.0m / Revenue TTM 22.71b)
Gross Margin = 40.38% ((Revenue TTM 22.71b - Cost of Revenue TTM 13.54b) / Revenue TTM)
Gross Margin QoQ = 41.89% (prev 41.99%)
Tobins Q-Ratio = 0.60 (Enterprise Value 10.20b / Total Assets 17.06b)
Interest Expense / Debt = 0.48% (Interest Expense 25.0m / Debt 5.24b)
Taxrate = 23.72% (181.0m / 763.0m)
NOPAT = 550.7m (EBIT 722.0m * (1 - 23.72%))
Current Ratio = 1.25 (Total Current Assets 7.38b / Total Current Liabilities 5.89b)
Debt / Equity = 1.21 (Debt 5.24b / totalStockholderEquity, last quarter 4.33b)
Debt / EBITDA = 2.96 (Net Debt 4.80b / EBITDA 1.62b)
Debt / FCF = 4.41 (Net Debt 4.80b / FCF TTM 1.09b)
Total Stockholder Equity = 4.45b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.78% (Net Income 478.0m / Total Assets 17.06b)
RoE = 10.75% (Net Income TTM 478.0m / Total Stockholder Equity 4.45b)
RoCE = 10.50% (EBIT 722.0m / Capital Employed (Equity 4.45b + L.T.Debt 2.43b))
RoIC = 7.76% (NOPAT 550.7m / Invested Capital 7.10b)
WACC = 5.91% (E(5.40b)/V(10.65b) * Re(11.29%) + D(5.24b)/V(10.65b) * Rd(0.48%) * (1-Tc(0.24)))
Discount Rate = 11.29% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.54%
[DCF Debug] Terminal Value 86.24% ; FCFF base≈741.8m ; Y1≈737.6m ; Y5≈772.1m
Fair Price DCF = 68.38 (EV 22.98b - Net Debt 4.80b = Equity 18.18b / Shares 265.9m; r=5.91% [WACC]; 5y FCF grow -1.25% → 2.90% )
EPS Correlation: -45.04 | EPS CAGR: -58.49% | SUE: -4.0 | # QB: 0
Revenue Correlation: -39.42 | Revenue CAGR: -14.73% | SUE: 1.49 | # QB: 4
EPS next Quarter (2026-04-30): EPS=0.17 | Chg30d=+0.005 | Revisions Net=+1 | Analysts=7
EPS next Year (2027-01-31): EPS=2.21 | Chg30d=+0.003 | Revisions Net=+3 | Growth EPS=+1.1% | Growth Revenue=-3.2%
P/E Forward = 11.2613
P/S = 0.2379
P/B = 1.2483
P/EG = 2.1667
Revenue TTM = 22.71b USD
EBIT TTM = 722.0m USD
EBITDA TTM = 1.62b USD
Long Term Debt = 2.43b USD (from longTermDebt, last quarter)
Short Term Debt = 6.00m USD (from shortTermDebt, last fiscal year)
Debt = 5.24b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.80b USD (from netDebt column, last quarter)
Enterprise Value = 10.20b USD (5.40b + Debt 5.24b - CCE 447.0m)
Interest Coverage Ratio = 7.37 (Ebit TTM 722.0m / Interest Expense TTM 98.0m)
EV/FCF = 9.38x (Enterprise Value 10.20b / FCF TTM 1.09b)
FCF Yield = 10.66% (FCF TTM 1.09b / Enterprise Value 10.20b)
FCF Margin = 4.79% (FCF TTM 1.09b / Revenue TTM 22.71b)
Net Margin = 2.10% (Net Income TTM 478.0m / Revenue TTM 22.71b)
Gross Margin = 40.38% ((Revenue TTM 22.71b - Cost of Revenue TTM 13.54b) / Revenue TTM)
Gross Margin QoQ = 41.89% (prev 41.99%)
Tobins Q-Ratio = 0.60 (Enterprise Value 10.20b / Total Assets 17.06b)
Interest Expense / Debt = 0.48% (Interest Expense 25.0m / Debt 5.24b)
Taxrate = 23.72% (181.0m / 763.0m)
NOPAT = 550.7m (EBIT 722.0m * (1 - 23.72%))
Current Ratio = 1.25 (Total Current Assets 7.38b / Total Current Liabilities 5.89b)
Debt / Equity = 1.21 (Debt 5.24b / totalStockholderEquity, last quarter 4.33b)
Debt / EBITDA = 2.96 (Net Debt 4.80b / EBITDA 1.62b)
Debt / FCF = 4.41 (Net Debt 4.80b / FCF TTM 1.09b)
Total Stockholder Equity = 4.45b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.78% (Net Income 478.0m / Total Assets 17.06b)
RoE = 10.75% (Net Income TTM 478.0m / Total Stockholder Equity 4.45b)
RoCE = 10.50% (EBIT 722.0m / Capital Employed (Equity 4.45b + L.T.Debt 2.43b))
RoIC = 7.76% (NOPAT 550.7m / Invested Capital 7.10b)
WACC = 5.91% (E(5.40b)/V(10.65b) * Re(11.29%) + D(5.24b)/V(10.65b) * Rd(0.48%) * (1-Tc(0.24)))
Discount Rate = 11.29% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.54%
[DCF Debug] Terminal Value 86.24% ; FCFF base≈741.8m ; Y1≈737.6m ; Y5≈772.1m
Fair Price DCF = 68.38 (EV 22.98b - Net Debt 4.80b = Equity 18.18b / Shares 265.9m; r=5.91% [WACC]; 5y FCF grow -1.25% → 2.90% )
EPS Correlation: -45.04 | EPS CAGR: -58.49% | SUE: -4.0 | # QB: 0
Revenue Correlation: -39.42 | Revenue CAGR: -14.73% | SUE: 1.49 | # QB: 4
EPS next Quarter (2026-04-30): EPS=0.17 | Chg30d=+0.005 | Revisions Net=+1 | Analysts=7
EPS next Year (2027-01-31): EPS=2.21 | Chg30d=+0.003 | Revisions Net=+3 | Growth EPS=+1.1% | Growth Revenue=-3.2%